Triple-negative breast cancer: current perspective on the evolving therapeutic landscape

Autor: Mehanna J, Haddad FGH, Eid R, Lambertini M, Kourie HR

Publikováno v: International Journal of Women's Health, Vol Volume 11, Pp 431-437 (2019)

Joe Mehanna,1 Fady GH Haddad,1 Roland Eid,1 Matteo Lambertini,2,3 Hampig Raphael Kourie11Oncology Department, Faculty of Medicine, Saint Joseph University of Beirut, Beirut, Lebanon; 2Department of Medical Oncology, U.O.C. Clinica Di Oncologia Medica

Externí odkaz: https://doaj.org/article/e878b343487d470b8d4824d00e002150

Emerging treatments for HER2-positive early-stage breast cancer: focus on neratinib

Autor: Kourie HR, El Rassy E, Clatot F, de Azambuja E, Lambertini M

Publikováno v: OncoTargets and Therapy, Vol Volume 10, Pp 3363-3372 (2017)

Hampig Raphael Kourie,1 Elie El Rassy,1 Florian Clatot,2,3 Evandro de Azambuja,4 Matteo Lambertini3,4 1Department of Oncology, Faculty of Medicine, Saint Joseph University, Beirut, Lebanon; 2Department of Medical Oncology and IRON/U1245, Centre Henri

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doajarticles::9cd5fcedae808607e131857e9b7d4af8
https://www.dovepress.com/emerging-treatments-for-her2-positive-early-stage-breast-cancer-focus--peer-reviewed-article-OTT

Career opportunities and benefits for young oncologists in the European Society for Medical Oncology (ESMO)

Autor: Keith McGregor, Valentina Guarneri, Andrés Cervantes, Gilberto Morgan, Alexander M.M. Eggermont, Jean-Yves Douillard, Martin Reck, Teresa Amaral, Matteo Lambertini, Hampig Raphael Kourie, Fortunato Ciardiello, Josep Tabernero, Fatima Cardoso, Raffaele Califano, George Pentheroudakis, Emile E. Voest, Erika Martinelli, Laurids Østergaard Poulsen, Alexandra Tyulyandina, Rolf A. Stahel, Guillem Argiles, Dirk Arnold, Matthias Preusser, Letticia De Mattos-Arruda, Christoph C. Zielinski, Vladimir Moiseyenko, Stefan Rauh, M. Strijbos, Paolo G. Casali, Akif Öztürk, Jacek Jassem, Mila Petrova, Alexandru Eniu, Pilar Garrido Lopez, Evandro de Azambuja, Solange Peters, Susana Banerjee, Radu Vidra, Claudia Cardone, Jesus Corral

Publikováno v: Morgan, G, Lambertini, M, Kourie, H R, Amaral, T, Argiles, G, Banerjee, S, Cardone, C, Corral, J, De Mattos-Arruda, L, Öztürk, A, Petrova, M, Poulsen, L, Strijbos, M, Tyulyandina, A, Vidra, R, Califano, R, de Azambuja, E, Garrido Lopez, P, Guarneri, V, Reck, M, Moiseyenko, V, Martinelli, E, Douillard, J-Y, Stahel, R, Voest, E, Arnold, D, Cardoso, F, Casali, P, Cervantes, A, Eggermont, A M M, Eniu, A, Jassem, J, Pentheroudakis, G, Peters, S, McGregor, K, Rauh, S, Zielinski, C C, Ciardiello, F, Tabernero, J & Preusser, M 2016, ' Career opportunities and benefits for young oncologists in the European Society for Medical Oncology (ESMO) ', ESMO Open, vol. 1, no. 6, e000107 . https://doi.org/10.1136/esmoopen-2016-000107
ESMO Open
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Esmo Open
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
ESMO Open, 1 (6

The European Society for Medical Oncology (ESMO) is one of the leading societies of oncology professionals in the world. Approximately 30% of the 13 000 ESMO members are below the age of 40 and thus meet the society's definition of young oncologists

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49fb31b4304bd595051beb235d3fbfc7
https://vbn.aau.dk/ws/files/266141093/e000107.full.pdf

Locally advanced/metastatic non-small-cell lung cancer in Lebanon: focus on ALK tyrosine kinase inhibitors.

Autor: Tfayli A; Hematology-Oncology Division, American University of Beirut Medical Center, Beirut, 1107 2020, Lebanon., Ghanem H; Hematology-Oncology Division, Lebanese American University Medical Center - Rizk Hospital, Beirut, 11-3288, Lebanon., Nasr F; Department of Hematology-Oncology, Hôtel-Dieu de France University Hospital, Faculty of Medicine, Saint-Joseph University of Beirut, Beirut, 166830, Lebanon., Kourie HR; Department of Hematology-Oncology, Hôtel-Dieu de France University Hospital, Faculty of Medicine, Saint-Joseph University of Beirut, Beirut, 166830, Lebanon., Hachem GE; Department of Hematology & Medical Oncology, Saint George Hospital University Medical Center, Beirut, Lebanon., Debs J; Pfizer Inc, 166-378, Levant., Masri S; Pfizer Inc, 166-378, Levant., Assi HI; Department of Internal Medicine, Naef K. Basile Cancer Institute, American University of Beirut Medical Center, Beirut, 1107 2020, Lebanon., Campelo RG; Department of Medical Oncology, Hospital Universitario A Coruña, 15006, A Coruña, Spain., Kattan J; Department of Hematology-Oncology, Hôtel-Dieu de France University Hospital, Faculty of Medicine, Saint-Joseph University of Beirut, Beirut, 166830, Lebanon.

Publikováno v: Future oncology (London, England) [Future Oncol] 2024 Nov 15, pp. 1-11. Date of Electronic Publication: 2024 Nov 15.

Characteristics and clinical outcomes of breast cancer in young BRCA carriers according to tumor histology.

Autor: Agostinetto E; Academic Trials Promoting Team, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Hôpital Universitaire de Bruxelles (HUB), Brussels, Belgium. Electronic address: elisa.agostinetto@hubruxelles.be., Bruzzone M; U.O. Epidemiologia Clinica, IRCCS Ospedale Policlinico San Martino, Genoa, Italy., Hamy AS; Department of Medical Oncology, Universite Paris Cité, Institut Curie, Paris, France., Kim HJ; Division of Breast Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea., Chiodi C; Cancer Survivorship Program - Molecular Predictors and New Targets in Oncology, INSERM Unit 981, Gustave Roussy, Villejuif, France., Bernstein-Molho R; Susanne Levy Gertner Oncogenetics Unit, The Danek Gertner Institute of Human Genetics, Chaim Sheba Medical Center Affiliated to Tel Aviv University, Tel Hashomer, Israel., Linn S; Department of Molecular Pathology, Netherlands Cancer Institute (NKI), Amsterdam, The Netherlands., Pogoda K; Department of Breast Cancer and Reconstructive Surgery, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Carrasco E; Hereditary Cancer Genetics Unit, Medical Oncology Department, Vall d´Hebron University Hospital, Vall d´Hebron Institute of Oncology (VHIO), Barcelona, Spain., Derouane F; Department of General Medical Oncology and Multidisciplinary Breast Center, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium., Bajpai J; Tata Memorial Centre, Homi Bhabha National Institute (HBNI), Mumbai, India., Nader-Marta G; Academic Trials Promoting Team, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Hôpital Universitaire de Bruxelles (HUB), Brussels, Belgium., Lopetegui-Lia N; Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland., Partridge AH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA., Cortesi L; Department of Oncology and Haematology, Azienda Ospedaliero-Universitaria di Modena, Modena, Italy., Rousset-Jablonski C; Department of Surgery, Leon Berard Cancer Center, Lyon; Hôpital Femme-Mère-Enfant, Hospices Civils de Lyon, Bron; Unité INSERM U1290 RESHAPE, Lyon., Giugliano F; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Renaud T; Cancer Genetics Unit, Bergonie Institute, Bordeaux, France., Ferrari A; Hereditary Breast and Ovarian Cancer (HBOC) Unit and General Surgery 3 - Senology, Surgical Department, Fondazione IRCCS Policlinico San Matteo, Pavia; University of Pavia, Pavia, Italy., Paluch-Shimon S; Breast Oncology Unit, Sharett Institute of Oncology, Hadassah University Hospital, Jerusalem; Faculty of Medicine, Hebrew University, Jerusalem, Israel., Fruscio R; UO Gynecology, Fondazione IRCCS San Gerardo, Monza; Department of Medicine and Surgery, University of Milan-Bicocca, Milan, Italy., Cui W; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria; Department of Medical Oncology, Peter MacCallum Cancer Center, Melbourne, Australia., Wong SM; Stroll Cancer Prevention Centre, Jewish General Hospital, Montreal; McGill University Medical School, Montreal, Canada., Vernieri C; Medical Oncology Department, Breast Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan; Oncology and Hematology-Oncology Department, University of Milan, Milan, Italy., Ruddy KJ; Department of Oncology, Mayo Clinic College of Medicine, Rochester, USA., Dieci MV; Department of Surgical, Oncological and Gastroenterological Sciences, Università di Padova, Padua; Oncologia 2, Istituto Oncologico Veneto IOV-IRCCS, Padua, Italy., Matikas A; Department of Oncology/Pathology, Karolinska Institute, Stockholm; Breast Center, Karolinska University Hospital, Stockholm, Sweden., Rozenblit M; Yale University, Medical Oncology, New Haven, USA., Aguilar Y Mendez D; Tecnologico de Monterrey, Breast Cancer Center, Hospital Zambrano Hellion - TecSalud, Monterrey, Mexico., De Marchis L; Division of Medical Oncology, Department of Radiological, Oncological and Pathological Sciences, 'La Sapienza' University of Rome, Rome; Oncology Unit, Umberto 1 University Hospital, Rome., Borea R; Medical Oncology Department, U.O.C. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genoa; Department of Internal Medicine and Medical Specialties (DIMI), School of Medicine, University of Genova, Genoa., Puglisi F; Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano; Department of Medicine, University of Udine, Udine., Pistelli M; Azienda Ospedaliero-Universitaria delle Marche, Ancona, Italy., Kufel-Grabowska J; Medical University of Gdańsk, Gdańsk, Poland., Di Rocco R; Department of Medical Oncology, Azienda USL Toscana Sud Est - Misericordia Hospital, Grosseto, Italy., Mariamidze E; Medical Oncology Department, U.O.C. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genoa; Department of Oncology and Hematology, Todua Clinic, Tbilisi, Georgia., Atzori F; Azienda Ospedaliero Universitaria di Cagliari, Cagliari, Italy., Kourie HR; Saint Joseph University of Beirut, Beirut, Lebanon., Popovic L; Oncology Institute of Vojvodina - Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia., de Azambuja E; Academic Trials Promoting Team, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Hôpital Universitaire de Bruxelles (HUB), Brussels, Belgium., Blondeaux E; U.O. Epidemiologia Clinica, IRCCS Ospedale Policlinico San Martino, Genoa, Italy., Lambertini M; Medical Oncology Department, U.O.C. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genoa; Department of Internal Medicine and Medical Specialties (DIMI), School of Medicine, University of Genova, Genoa.

Publikováno v: ESMO open [ESMO Open] 2024 Oct; Vol. 9 (10), pp. 103714. Date of Electronic Publication: 2024 Sep 16.